Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Charlotta Ljungman et al.|New England Journal of Medicine|2019Cited by 6.8k
The Seattle Heart Failure ModelWayne C. Levy, Milton Packer, Dariush Mozaffarian et al.|Circulation|2006Cited by 2k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality InitiativeClaudio Ronco, Peter A. McCullough, Stefan D. Anker et al.|European Heart Journal|2009Cited by 1.1k
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) TrialMarc A. Pfeffer, Bertram Pitt, Brian Claggett et al.|Circulation|2014Cited by 1k
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D. Solomon, Marc A. Pfeffer, Brian Claggett et al.|European Heart Journal|2015Cited by 524